nach oben

Erschienen in:

2011 | OriginalPaper | Buchkapitel

Nonpeptidic Delta (δ) Opioid Agonists and Antagonists of the Diarylmethylpiperazine Class: What Have We Learned?

verfasst von : Silvia N. Calderon

Erschienen in: Chemistry of Opioids

Verlag: Springer Berlin Heidelberg

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

The discovery of the selective delta (δ) opioid agonists SNC 80 and BW373U86, which possess a diarylmethylpiperazine structure unique among opioids, represented a major advance in the field of δ-opioid ligands. Extensive research has recently been performed to uncover the structure–activity relationships (SAR) of this class of ligands, thereby providing valuable tools for the pharmacological characterization of the δ opioid receptor. This review focuses on the SAR of this unique series of ligands, and provides an overview of the various chemical routes that have been developed and optimized through the years to allow the syntheses of these ligands on a multigram scale. The search for selective δ opioid agonists and antagonists, as well as for those with mixed opioid agonist properties with potential therapeutic value, continues. Several questions regarding the interaction at the molecular level of diphenylmethylpiperazine derivatives and related analogs with opioid receptors and in particular with the δ opioid system still remain unanswered. Indeed, the development and pharmacological characterization of novel nonpeptidic δ opioid ligands remains an active area of research, as it may provide a better understanding of the role of this receptor in multiple disease states and disorders.

Graphical Abstract

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Vorheriges Kapitel 14-Amino-4,5-Epoxymorphinan Derivatives and Their Pharmacological Actions

Nächstes Kapitel Synthesis of Neoclerodane Diterpenes and Their Pharmacological Effects

Pasternak GW (1993) Pharmacological mechanisms of opioid analgesics. Clin Neuropharmacol 16:1–18CrossRef

Quock RM, Burkey TH, Varga E et al (1999) The delta-opioid receptor: molecular pharmacology, signal transduction, and the determination of drug efficacy. Pharmacol Rev 51:503–532

Kieffer BL, Befort K, Gavriaux-Ruff C, Hirth CG (1992) The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci USA 89:12048–12052CrossRef

Evans CJ, Keith DE, Morrison H et al (1992) Cloning of a delta opioid receptor by functional expression. Science 258:1952–1955CrossRef

Mansson E, Bare L, Yang D (1994) Isolation of a human kappa opioid receptor cDNA from placenta. Biochem Biophys Res Commun 202:1431–1437CrossRef

Raynor K, Kong H, Chen Y et al (1994) Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Mol Pharmacol 45:330–334

Brandt MR, Furness MS, Mello NK et al (2001) Antinociceptive effects of delta opioid agonists in rhesus monkeys: effects on chemically induced thermal hypersensitivity. J Pharmacol Exp Ther 296:939–946

Mika J, Przewlocki R, Przewlocka B (2001) The role of delta opioid receptor subtypes in neuropathic pain. Eur J Pharmacol 415:31–37CrossRef

Craft RM, Henley SR, Haaseth RC et al (1995) Opioid antinociception in a rat model of visceral pain: systemic versus local drug administration. J Pharmacol Exp Ther 275:1535–1542

10.

Broom DC, Jutkiewicz EM, Rice KC et al (2002) Behavioral effects of δ-opioid receptor agonists: potential antidepressants? Jpn J Pharmacol 90:1–6CrossRef

11.

Jutkiewicz EM (2006) The antidepressant-like effects of delta-opioid receptor agonists. Mol Interv 6:162–169CrossRef

12.

Hallet PJ, Brotchie JM (2007) Striatal delta opioid receptor binding in experimental models of Parkinson’s disease and dyskinesia. Mov Disord 22:28–40CrossRef

13.

Shippenberg TS, LeFevour A, Chefer VI (2008) Targeting endogenous mu- and delta-opioid receptor systems for the treatment of drug addiction. CNS Neurol Disord Drug Targets 7:442–453CrossRef

14.

Corazziari E (1999) Role of opioid ligands in the irritable syndrome. Can J Gastroenterol 13(Suppl A):71A–75A

15.

Rapaka RS, Porreca F (1991) Development of delta opioid peptides as non-addicting analgesics. Pharm Res 8:1–8CrossRef

16.

Galligan JJ, Mosberg HI, Hurst R et al (1984) Cerebral delta opioid receptors mediate analgesia but not the intestinal motility effects of intracerebroventricularly administered opioids. J Pharmacol Exp Ther 229:641–648

17.

Reisine T, Pasternak G (1996) Opioid analgesics and antagonists. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gila AG (eds) Goodman & Gilman’s the pharmacological basis of therapeutics, 9th edn. McGraw-Hill, New York

18.

Heyl DL, Schullery SE (1997) Developments in the structure-activity relationships for the delta-selective opioid peptides of amphibian skin. Curr Med Chem 4:117–150

19.

Egleton RD, Davis TP (1997) Bioavailability and transport of peptides and peptide drugs into the brain. Peptides 18:1431–1439CrossRef

20.

Portoghese PS, Sultana M, Nagase H (1988) Application of message-address concept in the design of highly potent and selective non-peptide δ opioid receptor antagonists. J Med Chem 31:281–282CrossRef

21.

Schwyzer R (1977) ACTH: a short introductory review. Ann NY Acad Sci 297:3–26CrossRef

22.

Lee PHK, McNutt RW, Chang K-J. In: Abstracts of the 1992 college on problems of drug dependence- international narcotics research conference, Abstract 34

23.

Chang KJ, Rigdon GC, Howard JL, McNutt RW (1993) A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86. J Pharmacol Exp Ther 267:852–857

24.

Calderon SN, Rothman RB, Porreca F et al (1994) Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4-[(αR)-α-((2 S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3- methoxybenzyl]-N,N-diethylbenzamide (SNC 80): a highly selective, nonpeptide delta opioid receptor agonist. J Med Chem 37:2125–2128CrossRef

25.

Portoghese PS, Moe ST, Takemori AE (1993) A selective δ1 opioid receptor agonist derivative from oxymorphone. Evidence for separate recognition sites for δ1 opioid receptor agonists and antagonists. J Med Chem 36:2572–2574CrossRef

26.

Kamei J, Saitoh A, Ohsawa M et al (1995) Antinociceptive effects of the selective non-peptidic delta-opioid receptor agonist TAN-67 in diabetic mice. Eur J Pharmacol 276:131–135CrossRef

27.

Nagase H, Kawai K, Hayakawa J et al (1998) Rational drug design and synthesis of a highly selective nonpeptide δ-opioid agonist, (4aS*,12aR*)-4a-(3-hydroxyphenyl)-2-methyl-1,2,3,44a,12,12a-octahydropyrido[3,4-b]acridine (TAN-67). Chem Pharm Bull 46:1695–1702

28.

Dondio G, Ronzoni S, Petrillo P (1997) Non-peptide delta opioid agonists and antagonists. Exp Opin Ther Pat 7:1075–1098CrossRef

29.

Dondio G, Ronzoni S, Petrillo P (1999) Non-peptide delta opioid agonists and antagonists (part II). Exp Opin Ther Pat 9:353–374CrossRef

30.

Dondio G, Ronzoni S, Eggleson DS et al (1997) Discovery of a novel class of substituted pyrrolooctahydroisoquinolines as potent and selective delta opioid agonists, based on an extension of the message-address concept. J Med Chem 40:3192–3198CrossRef

31.

Su YF, McNutt RW, Chang KJ (1998) Delta-opioid ligands reverse alfentanil-induced respiratory depression but not antinociception. J Pharmacol Exp Ther 287:815–823

32.

Liras S, McHardy SF, Allen MP et al (2010) Biaryl piperidines as potent and selective delta opioid receptor ligands. Bioorg Med Chem Lett 20:503–507CrossRef

33.

Calderon SN, Coop A (2004) SNC 80 and related agonists. Curr Pharm Des 10:733–742CrossRef

34.

Chang K-J, Boswell GE, Bubacz DG, Collins MA, Davis AO, McNutt RW (1993) International Patent Application WO93/15062

35.

Wild KD, McCormick J, Bilsky EJ et al (1993) Antinociceptive actions of BW373U86 in the mouse. J Pharmacol Exp Ther 267:858–865

36.

Bilsky EJ, Calderon SN, Wang T et al (1995) SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist. J Pharmacol Exp Ther 273:359–366

37.

Calderon SN, Rice KC, Rothman RB et al (1997) Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(αR)-α-((2 S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid receptor ligands. J Med Chem 40:695–704CrossRef

38.

Katsura Y, Zhang X, Homma K et al (1997) Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (α-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists. J Med Chem 40:2936–2947CrossRef

39.

Bishop MJ, Garrido DM, Boswll GE et al (2003) 3-(αR)-α((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-alkyl-N-arylbenzamides: potent, non-peptidic agonists of both the μ and δ opioid receptors. J Med Chem 46:623–633CrossRef

40.

Middleton DS, Maw GN, Challenger C et al (2006) Highly potent and selective zwitterionic agonists of the delta-opioid receptor. Part 1. Bioorg Med Chem Lett 16:905–910CrossRef

41.

Zhang X, Rice KC, Calderon SN et al (1999) Probes for narcotic receptor mediated phenomena. 26. Synthesis and biological evaluation of diarylmethylpiperazines and diarylmethylpiperidines as novel, nonpeptidic delta opioid receptor ligands. J Med Chem 42:5455–5463CrossRef

42.

Cottney J, Rankovic Z, Morphy JR (1999) Synthesis of novel analogues of the delta opioid ligand SNC-80 using REM resin. Bioorg Med Chem Lett 9:1323–1328CrossRef

43.

Barn DR, Bom A, Cottney J et al (1999) Synthesis of novel analogues of the delta opioid ligand SNC-80 using AlCl3-promoted aminolysis. Bioorg Med Chem Lett 9:1329–1334CrossRef

44.

Delorme D, Berthelette C, Lavoie R, Roberts E (1998) Asymmetric synthesis of diarylmethylamines: preparation of selective opioid delta receptor ligands. Tetrahedron Asymmetry 9:3963–3966CrossRef

45.

Furness SC, Zhang X, Coop A et al (2000) Probes for narcotic receptor-mediated phenomena. 27. Synthesis and pharmacological evaluation of selective delta-opioid receptor agonists from 4-[(αR)-alpha-(2S,5R)-4-substituted-2,5-dimethyl-1-piperazinyl-3-methoxybenzyl]-N,N-diethylbenzamides and their enantiomers. J Med Chem 43:3193–3196CrossRef

46.

Pobleck N, Delorme D, Wei Z-Y et al (2000) New diarylmethylpiperazines as potent and selective nonpeptidic delta opioid receptor agonists with increased in vitro metabolic stability. J Med Chem 43:3878–3894CrossRef

47.

Liao S, Alfaro-Lopez J, Shenderovich MD et al (1998) De novo design, synthesis, and biological activities of high-affinity and selective non-peptide agonists of the delta-opioid receptor. J Med Chem 41:4767–4776CrossRef

48.

Alfaro-Lopez J, Okayama T, Hosohata K et al (1999) Exploring the structure-activity relationships of [1-(4-tert-butyl-3’-hydroxy)benzhydryl-4-benzylpiperazine] (SL-3111), a high-affinity and selective δ-opioid receptor nonpeptide agonist ligand. J Med Chem 42:5359–5368CrossRef

49.

Wei Z-Y, Brown W, Takasaki B et al (2000) N,N-Diethyl-4-(phenylpiperidin-4-ylidenemethyl)benzamide: a novel, exceptionally selective, potent delta opioid receptor agonist with oral bioavailability and its analogues. J Med Chem 43:3895–3905CrossRef

50.

Pelcman B, Roberts E (1998) International Patent Application WO 98/28270

51.

Thomas JB, Herault XM, Rothman RB et al (1999) (+/−)-4-[(N-Allyl-cis-3-methyl-4-piperidinyl)phenylamino]-N,N-diethylbenzamide displays selective binding for the delta opioid receptor. Bioorg Med Chem Lett 9:3053–3056CrossRef

52.

Thomas JB, Atkinson RN, Herault XM et al (1999) Optically pure (−)-4-[(N-allyl-3-methyl-4-piperidinyl)phenyl-amino]-N,N-diethylbenzamide displays selective binding and full agonist activity for the delta opioid receptor. Bioorg Med Chem Lett 9:3347–3350CrossRef

53.

Thomas JB, Herault XM, Rothman RB et al (2001) Factors influencing agonist potency and selectivity for the opioid delta receptor are revealed in structure-activity relationship studies of the 4-[(N-substituted-4-piperidinyl)arylamino]-N,N-diethylbenzamides. J Med Chem 44:972–987CrossRef

54.

Boyd RE, Carson JR, Codd EE et al (2000) Synthesis and binding affinities of 4-diarylaminotropanes, a new class of delta opioid agonists. Bioorg Med Chem Lett 10:1109–1111CrossRef

55.

Holl R, Jung B, Schepmann D et al (2009) Synthesis and pharmacological evaluation of SNC80 analogues with bridged piperazine ring. ChemMedChem 4:2111–2122CrossRef

56.

Bishop MJ, McNutt RW (1995) An efficient synthesis of the benzhydrylpiperazine delta opioid agonist (+)-BW373U86. Bioorg Med Chem Lett 5:1311–1314CrossRef

57.

Katritzky AR, Rachwal S, Rachwal B (1987) The chemistry of N-substituted benzotriazoles. Part 4. A novel and versatile method for the mono-N-alkylation of aromatic and heteroaromatic amines. J Chem Soc Perkin Trans I:805–809

58.

Katritzky AR, Yannakopoulou K, Lue P et al (1989) The chemistry of N-substituted benzotriazoles. Part 14. Novel routes to secondary and tertiary amines and N,N-disubstituted hydroxylamines. J Chem Soc Perkin Trans I:225–233

59.

Corey EJ, Helal CJ (1996) Catalytic enantioselective synthesis of the second generation histamine agonist cetirizine hydrochloride. Tetrahedron Lett 37:4837–4840CrossRef

60.

Janetka JW, Furness MS, Zhang X et al (2003) Enantioconvergent synthesis of (−)-(2R,5 S)-1-allyl-2,5-dimethylpiperazine, an intermediate to δ-opioid receptor ligands (2003). J Org Chem 68:3976–3980CrossRef

61.

Tomori H, Shibutami K, Ogura K (1997) Practical synthesis of (S)-3-(p-nitrobenzyloxycarbonylamino)pyrrolidine and its related compounds from -aspartic acid. Heterocycles 44:213–225CrossRef

Titel: Nonpeptidic Delta (δ) Opioid Agonists and Antagonists of the Diarylmethylpiperazine Class: What Have We Learned?
verfasst von: Silvia N. Calderon
Verlag: Springer Berlin Heidelberg
Buch: Chemistry of Opioids
Print ISBN: 978-3-642-18106-1

Electronic ISBN: 978-3-642-18107-8

Copyright-Jahr: 2011
DOI: https://doi.org/10.1007/128_2010_83